Institutional Governance · E-E-A-T Authority

About the Safe Infusion Therapy Initiative

An independent, clinician-led clinical authority platform dedicated to eliminating preventable intravenous complications through hospital-grade practice standards and patient education.

Clinical Peer Review: Sarah Jenkins, MSN, RN, CRNI, VA-BC Published: October 2026 Verified Board Member →

1. Institutional Mission & Origins

The Safe Infusion Therapy Initiative was founded to bridge the critical gap between complex clinical practice guidelines and practical execution at the hospital bedside and in home care. Built upon a decade of clinical heritage originating from B. Braun's international safe infusion research programs and Wikipedia's foundational reference for vascular access ports, the platform operates as an independent, non-commercial clinical knowledge base.

Our foundational mandate is simple: Zero preventable infusion harm. Every protocol, table, and decision aid is evaluated against primary peer-reviewed literature, randomized controlled trials, and international standards.

Tri-Disciplinary Leadership

Medical Review Board

Meet the accredited clinicians overseeing our content: board-certified medical oncologists (MD), infusion nurse specialists (CRNI), and sterile compounding pharmacists (PharmD).

GRADE Methodology · Independence

Editorial & Peer Review Policy

Examine our GRADE evidence rating methodology, 12-month mandatory review cycles, commercial independence charter, and transparent errata policy.

Clinical Practice Boundary Notice

This protocol provides evidence-based guidance reflecting INS 2024 Standards of Practice and CDC recommendations. Clinical judgment, institutional policy, and patient-specific variables must guide individualized bedside care.